Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADPS in Acne Vulgaris
NCT02935036Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing ADPS topical product with Placebo Control (2 arms). Primary endpoints: Percent Change From Baseline to Week 12 in the Inflammatory (Papules and Pustules) Lesion Counts on the Face, Percent Change From Baseline to Week 12 in the Non-inflammatory (Open and Closed Comedones) Lesion Counts on the Face and 1 more. Started Oct 2016; status: completed.
02
Drugs
ADPS
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02935036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935036.